The course has not only delved into theoretical aspects but has also provided practical insights into evaluating, comparing, and selecting appropriate hormone replacement medications based on patient characteristics and medical indications
Pharmaceutical targeting: Most current GLP-1 receptor agonists (like semaglutide, liraglutide) target only the GLP-1 receptor
Safety Profile and Drug Interactions Metformin and semaglutide have no direct pharmacokinetic interactions
Buldanlioglu, S
That is arguably a stronger safety model than reading a long written form with no follow-up clarification the clinician can ask clarifying questions in real time but it also means the $250 first-visit fee is committed before the clinician has seen any information
Branded GLP-1 medications are typically recommended for adults with a body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) with at least one weight-related comorbidity (such as high blood pressure, diabetes, sleep apnea, etc)